Bradley Olwin
Concepts (399)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Satellite Cells, Skeletal Muscle | 18 | 2026 | 36 | 5.790 |
Why?
| | Muscle, Skeletal | 33 | 2026 | 1818 | 3.800 |
Why?
| | Regeneration | 16 | 2026 | 199 | 3.000 |
Why?
| | Muscle Development | 15 | 2022 | 114 | 2.470 |
Why?
| | Muscle Fibers, Skeletal | 12 | 2024 | 216 | 2.240 |
Why?
| | Stem Cells | 9 | 2023 | 613 | 2.010 |
Why?
| | Fibroblast Growth Factors | 23 | 2017 | 187 | 1.830 |
Why?
| | Cell Differentiation | 31 | 2026 | 1982 | 1.270 |
Why?
| | Receptors, Fibroblast Growth Factor | 25 | 2001 | 70 | 1.200 |
Why?
| | MyoD Protein | 10 | 2015 | 31 | 1.030 |
Why?
| | Syndecan-3 | 5 | 2016 | 7 | 0.990 |
Why?
| | RNA Stability | 3 | 2016 | 119 | 0.920 |
Why?
| | PAX7 Transcription Factor | 6 | 2024 | 13 | 0.890 |
Why?
| | Mice | 46 | 2026 | 18297 | 0.780 |
Why?
| | Stem Cell Niche | 2 | 2016 | 57 | 0.750 |
Why?
| | Animals | 77 | 2026 | 38107 | 0.690 |
Why?
| | DNA-Binding Proteins | 3 | 2026 | 1468 | 0.660 |
Why?
| | Mitogen-Activated Protein Kinase 11 | 2 | 2014 | 3 | 0.630 |
Why?
| | Mitogen-Activated Protein Kinase 14 | 2 | 2014 | 7 | 0.630 |
Why?
| | Extremities | 9 | 2011 | 142 | 0.630 |
Why?
| | Cell Nucleus | 1 | 2023 | 584 | 0.610 |
Why?
| | Muscles | 14 | 2016 | 330 | 0.570 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 2020 | 92 | 0.570 |
Why?
| | Receptors, Cell Surface | 11 | 2011 | 371 | 0.550 |
Why?
| | Cell Separation | 2 | 2017 | 300 | 0.540 |
Why?
| | Muscle, Striated | 1 | 2018 | 12 | 0.530 |
Why?
| | Lipoprotein Lipase | 1 | 2018 | 55 | 0.520 |
Why?
| | Pluripotent Stem Cells | 1 | 2018 | 78 | 0.520 |
Why?
| | Signal Transduction | 17 | 2017 | 5246 | 0.510 |
Why?
| | Fluorescent Antibody Technique | 4 | 2016 | 345 | 0.510 |
Why?
| | Teratoma | 1 | 2018 | 121 | 0.500 |
Why?
| | Fibroblast Growth Factor 2 | 9 | 1998 | 93 | 0.500 |
Why?
| | Stem Cell Transplantation | 2 | 2017 | 190 | 0.470 |
Why?
| | Cell Division | 14 | 2004 | 736 | 0.460 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2015 | 263 | 0.460 |
Why?
| | Genetic Therapy | 1 | 2018 | 303 | 0.450 |
Why?
| | Chick Embryo | 15 | 2011 | 132 | 0.450 |
Why?
| | Homeostasis | 2 | 2016 | 646 | 0.450 |
Why?
| | Tristetraprolin | 1 | 2015 | 8 | 0.440 |
Why?
| | Myoblasts | 6 | 2021 | 84 | 0.440 |
Why?
| | Fibroblast Growth Factor 1 | 5 | 2014 | 12 | 0.430 |
Why?
| | Cell Transplantation | 2 | 2014 | 39 | 0.420 |
Why?
| | Cell Proliferation | 9 | 2016 | 2502 | 0.420 |
Why?
| | Cell Culture Techniques | 2 | 2023 | 371 | 0.420 |
Why?
| | Cell Cycle | 5 | 2010 | 595 | 0.420 |
Why?
| | Proteoglycans | 4 | 2004 | 111 | 0.420 |
Why?
| | RNA, Messenger | 4 | 2018 | 2791 | 0.400 |
Why?
| | Cell Line | 19 | 2012 | 2814 | 0.400 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2011 | 117 | 0.390 |
Why?
| | Syndecan-4 | 3 | 2009 | 6 | 0.390 |
Why?
| | Receptors, Notch | 2 | 2012 | 92 | 0.390 |
Why?
| | Asymmetric Cell Division | 1 | 2012 | 1 | 0.380 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2014 | 266 | 0.370 |
Why?
| | Cellular Senescence | 2 | 2015 | 225 | 0.360 |
Why?
| | Mechanotransduction, Cellular | 2 | 2024 | 121 | 0.350 |
Why?
| | Hedgehog Proteins | 2 | 2011 | 194 | 0.350 |
Why?
| | Cell Adhesion Molecules | 1 | 2012 | 180 | 0.340 |
Why?
| | Rhabdomyosarcoma, Alveolar | 1 | 2011 | 7 | 0.340 |
Why?
| | Neoplasms, Muscle Tissue | 1 | 2011 | 3 | 0.340 |
Why?
| | Avian Proteins | 1 | 2011 | 21 | 0.340 |
Why?
| | Cysteine | 4 | 1997 | 210 | 0.330 |
Why?
| | Down Syndrome | 1 | 2018 | 529 | 0.330 |
Why?
| | Membrane Glycoproteins | 3 | 2004 | 495 | 0.320 |
Why?
| | ras Proteins | 2 | 2002 | 148 | 0.320 |
Why?
| | Cells, Cultured | 15 | 2018 | 4118 | 0.310 |
Why?
| | Forkhead Transcription Factors | 1 | 2011 | 209 | 0.310 |
Why?
| | Retroviridae | 5 | 2018 | 99 | 0.300 |
Why?
| | Receptor Protein-Tyrosine Kinases | 3 | 2001 | 227 | 0.290 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2011 | 213 | 0.290 |
Why?
| | Transfection | 8 | 2016 | 916 | 0.290 |
Why?
| | Calmodulin | 8 | 1985 | 70 | 0.280 |
Why?
| | Aging | 6 | 2023 | 1996 | 0.280 |
Why?
| | Gene Expression | 5 | 2023 | 1463 | 0.280 |
Why?
| | Muscular Diseases | 2 | 2020 | 110 | 0.270 |
Why?
| | Isoenzymes | 2 | 2012 | 294 | 0.250 |
Why?
| | Myogenin | 4 | 2012 | 15 | 0.250 |
Why?
| | Mice, Knockout | 4 | 2018 | 3125 | 0.250 |
Why?
| | RNA-Binding Proteins | 3 | 2022 | 465 | 0.250 |
Why?
| | Hydrogels | 2 | 2024 | 708 | 0.240 |
Why?
| | Protein Kinase C | 2 | 2012 | 250 | 0.240 |
Why?
| | Adult Stem Cells | 2 | 2017 | 39 | 0.240 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1432 | 0.220 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2021 | 429 | 0.210 |
Why?
| | Base Sequence | 9 | 2015 | 2123 | 0.210 |
Why?
| | Integrins | 1 | 2024 | 88 | 0.210 |
Why?
| | Mice, Inbred C57BL | 5 | 2018 | 6034 | 0.200 |
Why?
| | Elasticity | 1 | 2024 | 187 | 0.200 |
Why?
| | Molecular Sequence Data | 10 | 2015 | 2838 | 0.200 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2002 | 288 | 0.190 |
Why?
| | Trans-Activators | 2 | 2021 | 372 | 0.180 |
Why?
| | Enzyme Activation | 5 | 2012 | 759 | 0.180 |
Why?
| | Gene Expression Regulation | 4 | 2007 | 2599 | 0.180 |
Why?
| | Homeodomain Proteins | 2 | 2004 | 525 | 0.180 |
Why?
| | Genetic Vectors | 3 | 2018 | 327 | 0.170 |
Why?
| | Microscopy | 1 | 2023 | 147 | 0.170 |
Why?
| | Flow Cytometry | 2 | 2017 | 1163 | 0.170 |
Why?
| | Binding Sites | 6 | 2015 | 1309 | 0.170 |
Why?
| | Models, Biological | 3 | 2018 | 1761 | 0.160 |
Why?
| | Mesoderm | 5 | 1995 | 147 | 0.160 |
Why?
| | Muscle Proteins | 4 | 1996 | 242 | 0.160 |
Why?
| | Cell Membrane | 5 | 2010 | 701 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 170 | 0.150 |
Why?
| | Contracture | 1 | 2020 | 23 | 0.150 |
Why?
| | Education | 1 | 2020 | 103 | 0.150 |
Why?
| | Research Report | 1 | 2020 | 89 | 0.150 |
Why?
| | Receptors, Platelet-Derived Growth Factor | 2 | 1998 | 14 | 0.150 |
Why?
| | Genes, Reporter | 4 | 2002 | 275 | 0.150 |
Why?
| | Cell Survival | 3 | 2012 | 1105 | 0.140 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2001 | 429 | 0.140 |
Why?
| | TDP-43 Proteinopathies | 1 | 2018 | 6 | 0.140 |
Why?
| | Virulence Factors, Bordetella | 1 | 1998 | 15 | 0.140 |
Why?
| | Pertussis Toxin | 1 | 1998 | 24 | 0.140 |
Why?
| | Neuromuscular Diseases | 1 | 2020 | 146 | 0.140 |
Why?
| | Musculoskeletal Diseases | 1 | 2020 | 95 | 0.140 |
Why?
| | Protein Binding | 11 | 2015 | 2244 | 0.140 |
Why?
| | GTP-Binding Proteins | 1 | 1998 | 150 | 0.130 |
Why?
| | 3' Untranslated Regions | 2 | 2016 | 152 | 0.130 |
Why?
| | Recombinant Proteins | 8 | 2016 | 1361 | 0.130 |
Why?
| | Amyloid | 1 | 2018 | 90 | 0.130 |
Why?
| | Hypertriglyceridemia | 1 | 2018 | 45 | 0.130 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2018 | 70 | 0.130 |
Why?
| | Muscular Dystrophies | 2 | 2010 | 29 | 0.130 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 307 | 0.130 |
Why?
| | Platelet-Derived Growth Factor | 2 | 1995 | 85 | 0.120 |
Why?
| | Cell Self Renewal | 1 | 2017 | 50 | 0.120 |
Why?
| | Nervous System Diseases | 1 | 2020 | 288 | 0.120 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2016 | 3 | 0.120 |
Why?
| | Growth Differentiation Factors | 1 | 2016 | 1 | 0.120 |
Why?
| | Biomarkers | 3 | 2017 | 4340 | 0.120 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2001 | 59 | 0.110 |
Why?
| | Mice, Mutant Strains | 3 | 2004 | 290 | 0.110 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 1 | 2015 | 46 | 0.110 |
Why?
| | Phenotype | 3 | 2014 | 3206 | 0.110 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2016 | 143 | 0.110 |
Why?
| | Wings, Animal | 2 | 1995 | 39 | 0.110 |
Why?
| | Heparin | 5 | 2001 | 247 | 0.110 |
Why?
| | Calcium | 5 | 1985 | 1181 | 0.110 |
Why?
| | DNA Damage | 1 | 2018 | 439 | 0.110 |
Why?
| | Humans | 22 | 2023 | 146342 | 0.100 |
Why?
| | Mice, Inbred DBA | 1 | 2014 | 186 | 0.100 |
Why?
| | Laminin | 2 | 2001 | 72 | 0.100 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2015 | 198 | 0.100 |
Why?
| | Calmodulin-Binding Proteins | 5 | 1985 | 14 | 0.100 |
Why?
| | Heparan Sulfate Proteoglycans | 3 | 2001 | 23 | 0.090 |
Why?
| | Extracellular Matrix Proteins | 1 | 1994 | 156 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 633 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2015 | 902 | 0.090 |
Why?
| | Muscle Cells | 1 | 2012 | 41 | 0.090 |
Why?
| | Molecular Weight | 6 | 1991 | 295 | 0.090 |
Why?
| | Chlorates | 3 | 2001 | 4 | 0.090 |
Why?
| | Environment | 1 | 2014 | 299 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 457 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2014 | 752 | 0.090 |
Why?
| | Immunohistochemistry | 4 | 2002 | 1712 | 0.090 |
Why?
| | Ligands | 1 | 2014 | 678 | 0.090 |
Why?
| | Patched Receptors | 1 | 2011 | 14 | 0.090 |
Why?
| | Butadienes | 2 | 2002 | 34 | 0.090 |
Why?
| | Multiprotein Complexes | 1 | 2012 | 168 | 0.080 |
Why?
| | Forkhead Box Protein O1 | 1 | 2011 | 36 | 0.080 |
Why?
| | Fibroblasts | 2 | 2000 | 1034 | 0.080 |
Why?
| | Cattle | 9 | 1993 | 940 | 0.080 |
Why?
| | Kinetics | 11 | 1988 | 1553 | 0.080 |
Why?
| | Transduction, Genetic | 1 | 2011 | 129 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2007 | 834 | 0.080 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2010 | 24 | 0.080 |
Why?
| | Cricetinae | 4 | 1997 | 296 | 0.080 |
Why?
| | Nitriles | 2 | 2002 | 212 | 0.080 |
Why?
| | Embryonic and Fetal Development | 1 | 1990 | 90 | 0.080 |
Why?
| | Graft Survival | 1 | 2012 | 523 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 384 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2134 | 0.080 |
Why?
| | Binding, Competitive | 4 | 1997 | 185 | 0.070 |
Why?
| | Female | 8 | 2018 | 79499 | 0.070 |
Why?
| | Transcription, Genetic | 3 | 2011 | 1432 | 0.070 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 5 | 1990 | 326 | 0.070 |
Why?
| | Naphthalenesulfonates | 3 | 1984 | 8 | 0.070 |
Why?
| | Green Fluorescent Proteins | 1 | 2010 | 408 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 1991 | 237 | 0.070 |
Why?
| | Cartilage | 3 | 1995 | 198 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2012 | 630 | 0.070 |
Why?
| | Proto-Oncogene Proteins | 3 | 2000 | 616 | 0.070 |
Why?
| | Extracellular Matrix | 3 | 2000 | 565 | 0.070 |
Why?
| | Enzyme Inhibitors | 2 | 2002 | 823 | 0.070 |
Why?
| | Hindlimb | 2 | 2002 | 128 | 0.060 |
Why?
| | DNA Primers | 4 | 2002 | 487 | 0.060 |
Why?
| | Polysaccharide-Lyases | 3 | 1992 | 11 | 0.060 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 2 | 1998 | 32 | 0.060 |
Why?
| | Phosphoprotein Phosphatases | 2 | 1984 | 67 | 0.060 |
Why?
| | Protein Interaction Mapping | 1 | 2007 | 105 | 0.060 |
Why?
| | Calcium-Binding Proteins | 3 | 1982 | 221 | 0.060 |
Why?
| | CHO Cells | 3 | 1997 | 167 | 0.060 |
Why?
| | DNA | 4 | 1998 | 1421 | 0.060 |
Why?
| | Tissue Engineering | 1 | 2010 | 442 | 0.060 |
Why?
| | Protein Kinases | 2 | 1986 | 311 | 0.060 |
Why?
| | Embryo, Mammalian | 2 | 2001 | 230 | 0.060 |
Why?
| | Troponin | 2 | 1982 | 50 | 0.060 |
Why?
| | ErbB Receptors | 1 | 1988 | 636 | 0.050 |
Why?
| | Ectoderm | 3 | 1994 | 53 | 0.050 |
Why?
| | Calcium Chloride | 1 | 1984 | 10 | 0.050 |
Why?
| | Mitosis | 2 | 2001 | 195 | 0.050 |
Why?
| | Viscosity | 1 | 2024 | 91 | 0.050 |
Why?
| | Amino Acid Sequence | 5 | 1997 | 2092 | 0.050 |
Why?
| | Carbohydrate Sequence | 2 | 1994 | 29 | 0.050 |
Why?
| | Time Factors | 3 | 2014 | 7109 | 0.050 |
Why?
| | Myosin Heavy Chains | 1 | 2005 | 177 | 0.050 |
Why?
| | RNA | 2 | 2020 | 926 | 0.050 |
Why?
| | Azirines | 1 | 1982 | 2 | 0.050 |
Why?
| | Dansyl Compounds | 1 | 1982 | 4 | 0.050 |
Why?
| | Aziridines | 1 | 1982 | 6 | 0.050 |
Why?
| | Oligopeptides | 1 | 2024 | 264 | 0.050 |
Why?
| | Glycosaminoglycans | 2 | 1994 | 79 | 0.050 |
Why?
| | Blotting, Western | 1 | 2004 | 1177 | 0.040 |
Why?
| | Male | 5 | 2018 | 73396 | 0.040 |
Why?
| | Carbazoles | 1 | 2002 | 53 | 0.040 |
Why?
| | Forelimb | 1 | 2001 | 42 | 0.040 |
Why?
| | Suramin | 1 | 2001 | 8 | 0.040 |
Why?
| | Autocrine Communication | 1 | 2001 | 38 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2001 | 76 | 0.040 |
Why?
| | Cell Fusion | 1 | 2001 | 47 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2001 | 46 | 0.040 |
Why?
| | MAP Kinase Kinase 2 | 1 | 2001 | 28 | 0.040 |
Why?
| | Alternative Splicing | 2 | 2020 | 253 | 0.040 |
Why?
| | G1 Phase | 1 | 2001 | 64 | 0.040 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2001 | 70 | 0.040 |
Why?
| | S Phase | 1 | 2001 | 77 | 0.040 |
Why?
| | Myogenic Regulatory Factors | 1 | 2000 | 45 | 0.040 |
Why?
| | Chickens | 2 | 2000 | 169 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 4 | 1985 | 165 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 126 | 0.040 |
Why?
| | Polyadenylation | 1 | 2020 | 41 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 134 | 0.040 |
Why?
| | Flavonoids | 1 | 2001 | 85 | 0.040 |
Why?
| | Somites | 1 | 2000 | 5 | 0.040 |
Why?
| | Chicago | 1 | 2020 | 62 | 0.040 |
Why?
| | Transcription Factors | 2 | 2021 | 1730 | 0.040 |
Why?
| | Species Specificity | 2 | 2012 | 543 | 0.040 |
Why?
| | Autoradiography | 2 | 1990 | 65 | 0.040 |
Why?
| | Fluorescent Dyes | 4 | 1985 | 340 | 0.040 |
Why?
| | Body Patterning | 1 | 2000 | 137 | 0.040 |
Why?
| | DNA Replication | 3 | 1992 | 248 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2023 | 432 | 0.040 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2020 | 93 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2001 | 888 | 0.040 |
Why?
| | Cholera Toxin | 1 | 1998 | 27 | 0.040 |
Why?
| | Colforsin | 1 | 1998 | 47 | 0.040 |
Why?
| | Thionucleotides | 1 | 1998 | 35 | 0.040 |
Why?
| | Promoter Regions, Genetic | 2 | 2010 | 1242 | 0.030 |
Why?
| | Cross-Linking Reagents | 2 | 1989 | 208 | 0.030 |
Why?
| | Sarcomeres | 1 | 2018 | 100 | 0.030 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1998 | 141 | 0.030 |
Why?
| | Polyethylene Glycols | 1 | 2023 | 650 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2001 | 303 | 0.030 |
Why?
| | Cytoplasm | 1 | 2018 | 253 | 0.030 |
Why?
| | Indoles | 1 | 2002 | 511 | 0.030 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2018 | 98 | 0.030 |
Why?
| | Tyrosine | 1 | 1998 | 217 | 0.030 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 1997 | 45 | 0.030 |
Why?
| | Carrier Proteins | 3 | 1991 | 728 | 0.030 |
Why?
| | Cerebral Palsy | 1 | 2020 | 149 | 0.030 |
Why?
| | Subcellular Fractions | 1 | 1997 | 73 | 0.030 |
Why?
| | Proteins | 1 | 2023 | 1022 | 0.030 |
Why?
| | Cell Movement | 1 | 2001 | 951 | 0.030 |
Why?
| | Bone and Bones | 1 | 2000 | 319 | 0.030 |
Why?
| | Fluorescence Polarization | 4 | 1985 | 24 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1997 | 99 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 1997 | 139 | 0.030 |
Why?
| | Thermodynamics | 3 | 1984 | 420 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1998 | 526 | 0.030 |
Why?
| | Myocardium | 2 | 2016 | 948 | 0.030 |
Why?
| | Parabiosis | 1 | 2016 | 11 | 0.030 |
Why?
| | Smad3 Protein | 1 | 2016 | 41 | 0.030 |
Why?
| | Fibroblast Growth Factor 4 | 2 | 1993 | 19 | 0.030 |
Why?
| | Smad2 Protein | 1 | 2016 | 37 | 0.030 |
Why?
| | Myostatin | 1 | 2016 | 24 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 1995 | 52 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2016 | 128 | 0.030 |
Why?
| | Salamandridae | 1 | 1995 | 33 | 0.030 |
Why?
| | Hypertrophy | 1 | 2016 | 127 | 0.030 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2015 | 15 | 0.030 |
Why?
| | Biological Transport | 1 | 1997 | 424 | 0.030 |
Why?
| | Gene Deletion | 1 | 1997 | 385 | 0.030 |
Why?
| | Second Messenger Systems | 1 | 1995 | 31 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2016 | 195 | 0.030 |
Why?
| | Phosphorylation | 2 | 1998 | 1724 | 0.030 |
Why?
| | Nucleic Acid Conformation | 1 | 1998 | 724 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2016 | 313 | 0.030 |
Why?
| | Ubiquitination | 1 | 2015 | 119 | 0.030 |
Why?
| | Cachexia | 1 | 2016 | 74 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 1994 | 16 | 0.030 |
Why?
| | Brain | 5 | 1990 | 2991 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 155 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 387 | 0.030 |
Why?
| | MicroRNAs | 1 | 2020 | 699 | 0.030 |
Why?
| | Olfactory Receptor Neurons | 1 | 1994 | 42 | 0.030 |
Why?
| | Aggrecans | 1 | 1994 | 15 | 0.030 |
Why?
| | Lectins, C-Type | 1 | 1994 | 61 | 0.030 |
Why?
| | Chondroitin Sulfates | 1 | 1994 | 35 | 0.020 |
Why?
| | Actins | 1 | 1996 | 422 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1994 | 122 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1994 | 1041 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 1996 | 663 | 0.020 |
Why?
| | 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 1983 | 8 | 0.020 |
Why?
| | Protein Sorting Signals | 1 | 1992 | 21 | 0.020 |
Why?
| | N-Glycosyl Hydrolases | 1 | 1992 | 6 | 0.020 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1993 | 92 | 0.020 |
Why?
| | Genetic Techniques | 1 | 1993 | 64 | 0.020 |
Why?
| | Osteogenesis | 1 | 1994 | 205 | 0.020 |
Why?
| | Sulfates | 1 | 1992 | 45 | 0.020 |
Why?
| | Rabbits | 2 | 1984 | 651 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2012 | 165 | 0.020 |
Why?
| | Immunotoxins | 1 | 1992 | 51 | 0.020 |
Why?
| | Heart | 1 | 2016 | 626 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1992 | 382 | 0.020 |
Why?
| | Structure-Activity Relationship | 2 | 1991 | 563 | 0.020 |
Why?
| | Arterial Occlusive Diseases | 1 | 1992 | 88 | 0.020 |
Why?
| | Mice, SCID | 1 | 2012 | 360 | 0.020 |
Why?
| | Angioplasty, Balloon | 1 | 1992 | 92 | 0.020 |
Why?
| | Dogs | 1 | 2012 | 517 | 0.020 |
Why?
| | Cell Communication | 1 | 2012 | 327 | 0.020 |
Why?
| | Mice, Inbred mdx | 1 | 2010 | 12 | 0.020 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1989 | 9 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1989 | 588 | 0.020 |
Why?
| | Succinimides | 1 | 1989 | 21 | 0.020 |
Why?
| | Amidohydrolases | 1 | 1989 | 31 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1989 | 82 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 1992 | 449 | 0.020 |
Why?
| | Muscle, Smooth, Vascular | 1 | 1992 | 449 | 0.020 |
Why?
| | Mutation | 2 | 2000 | 4093 | 0.020 |
Why?
| | Oligosaccharides | 1 | 1989 | 62 | 0.020 |
Why?
| | Immunity | 1 | 2010 | 141 | 0.020 |
Why?
| | Aorta | 1 | 1992 | 440 | 0.020 |
Why?
| | Eye | 1 | 1990 | 112 | 0.020 |
Why?
| | Tissue Distribution | 1 | 1989 | 334 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1989 | 534 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2012 | 901 | 0.020 |
Why?
| | Phosphoric Diester Hydrolases | 2 | 1985 | 53 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3416 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 1988 | 152 | 0.020 |
Why?
| | Liver | 2 | 1990 | 1864 | 0.020 |
Why?
| | Immunosorbent Techniques | 1 | 1985 | 16 | 0.010 |
Why?
| | Aminoquinolines | 1 | 1985 | 18 | 0.010 |
Why?
| | Immunologic Techniques | 1 | 1985 | 36 | 0.010 |
Why?
| | Receptors, Cholinergic | 1 | 1985 | 42 | 0.010 |
Why?
| | Rats | 3 | 1992 | 5586 | 0.010 |
Why?
| | DNA, Complementary | 2 | 1995 | 269 | 0.010 |
Why?
| | Troponin I | 2 | 1982 | 74 | 0.010 |
Why?
| | Adenylyl Cyclases | 1 | 1985 | 60 | 0.010 |
Why?
| | Methionine | 1 | 1985 | 160 | 0.010 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 1984 | 19 | 0.010 |
Why?
| | 3T3 Cells | 2 | 1995 | 152 | 0.010 |
Why?
| | Membrane Proteins | 1 | 1991 | 1130 | 0.010 |
Why?
| | Myofibrils | 1 | 1984 | 55 | 0.010 |
Why?
| | Phosphatidylcholines | 1 | 1985 | 131 | 0.010 |
Why?
| | Horseshoe Crabs | 1 | 1983 | 2 | 0.010 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1983 | 113 | 0.010 |
Why?
| | Mathematics | 1 | 1984 | 102 | 0.010 |
Why?
| | Age Factors | 1 | 1991 | 3347 | 0.010 |
Why?
| | Liposomes | 1 | 1985 | 269 | 0.010 |
Why?
| | Adenylyl Cyclase Inhibitors | 1 | 1980 | 7 | 0.010 |
Why?
| | Biological Assay | 2 | 1994 | 133 | 0.010 |
Why?
| | COS Cells | 1 | 2000 | 173 | 0.010 |
Why?
| | Homozygote | 1 | 2000 | 197 | 0.010 |
Why?
| | Templates, Genetic | 1 | 1998 | 63 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1980 | 494 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 1980 | 485 | 0.010 |
Why?
| | Limb Buds | 1 | 1995 | 21 | 0.010 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1995 | 28 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 1995 | 317 | 0.010 |
Why?
| | Olfactory Mucosa | 1 | 1994 | 39 | 0.010 |
Why?
| | MSX1 Transcription Factor | 1 | 1994 | 5 | 0.010 |
Why?
| | Genes, Homeobox | 1 | 1994 | 50 | 0.010 |
Why?
| | Antibody Specificity | 1 | 1993 | 181 | 0.010 |
Why?
| | Limb Deformities, Congenital | 1 | 1993 | 22 | 0.010 |
Why?
| | Ribosome Inactivating Proteins, Type 1 | 1 | 1992 | 3 | 0.010 |
Why?
| | Cell Death | 1 | 1994 | 379 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 316 | 0.010 |
Why?
| | Morphogenesis | 1 | 1993 | 163 | 0.010 |
Why?
| | Plant Proteins | 1 | 1992 | 110 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1993 | 1244 | 0.010 |
Why?
| | Magnesium | 2 | 1982 | 155 | 0.010 |
Why?
| | Antibodies | 1 | 1992 | 400 | 0.000 |
Why?
| | Interphase | 1 | 1987 | 38 | 0.000 |
Why?
| | Peptides | 1 | 1992 | 992 | 0.000 |
Why?
| | Guanosine Triphosphate | 1 | 1986 | 88 | 0.000 |
Why?
| | Macromolecular Substances | 1 | 1986 | 205 | 0.000 |
Why?
| | Ribosomal Proteins | 1 | 1986 | 93 | 0.000 |
Why?
| | Stereoisomerism | 1 | 1983 | 102 | 0.000 |
Why?
| | Substrate Specificity | 1 | 1983 | 389 | 0.000 |
Why?
| | Magnesium Chloride | 1 | 1982 | 7 | 0.000 |
Why?
| | Potassium Chloride | 1 | 1982 | 41 | 0.000 |
Why?
| | Temperature | 1 | 1985 | 635 | 0.000 |
Why?
| | Chromatography, Gel | 1 | 1982 | 131 | 0.000 |
Why?
| | Osmolar Concentration | 1 | 1982 | 165 | 0.000 |
Why?
| | Fatty Acids | 1 | 1985 | 460 | 0.000 |
Why?
| | Edetic Acid | 1 | 1980 | 47 | 0.000 |
Why?
| | Manganese | 1 | 1980 | 59 | 0.000 |
Why?
| | Peptide Fragments | 1 | 1983 | 693 | 0.000 |
Why?
| | Biological Evolution | 1 | 1983 | 471 | 0.000 |
Why?
| | Protein Conformation | 1 | 1981 | 916 | 0.000 |
Why?
|
|
Olwin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|